Name | Type | Posted | Actions |
|---|---|---|---|
36E79725D0052_1.docx | DOCX | Aug 25, 2025 |
6505--RSV Vaccine Effective 10/01/2025-09/30/30
Contact and place of performance
Deborah Fassl
Not specified
No narrative description provided for this notice.
The Department of Veterans Affairs, NAC Pharmaceuticals (36E797), issued this award notice for the procurement of RSV vaccines under solicitation number 36E79725R0043. The contract, identified by award number 36E79725D0052, establishes a period of performance effective from October 1, 2025, through September 30, 2030.
This requirement is classified under NAICS 325412 for Pharmaceutical Preparation Manufacturing and PSC 6505 for Drugs and Biologicals. Deborah Fassl serves as the primary point of contact for this award, which was published and updated on August 25, 2025. One associated document, a Word file titled 36E79725D0052_1.docx, was included with the notice.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.